Literature DB >> 15454880

[Central dopamine receptors: general considerations (Part 1)].

R Bordet1.   

Abstract

Specific protein G-coupled receptors mediate the effects of dopamine in its projection areas. Five dopaminergic receptors have been cloned, characterized and classified in two families, the D1-like family (D1- and D5-receptor subtypes) and the D2-like family (D2-, D3- and D4-receptor subtypes). These five dopamine receptor subtypes are characterized by their diversity in terms of transduction, distribution, pharmacology, functions, and regulation, leading to pleiotropic pathophysiological and pharmacological involvements in neuropsychiatric disorders underlain by a deregulation of the dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454880     DOI: 10.1016/s0035-3787(04)71067-x

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  8 in total

1.  Iron deficiency anemia in infancy exerts long-term effects on the tibialis anterior motor activity during sleep in childhood.

Authors:  Patricio Peirano; Cecilia Algarin; Rodrigo Chamorro; Mauro Manconi; Betsy Lozoff; Raffaele Ferri
Journal:  Sleep Med       Date:  2012-07-04       Impact factor: 3.492

2.  Synthesis and pharmacological evaluation of fluorine-containing D₃ dopamine receptor ligands.

Authors:  Zhude Tu; Shihong Li; Jinquan Cui; Jinbin Xu; Michelle Taylor; David Ho; Robert R Luedtke; Robert H Mach
Journal:  J Med Chem       Date:  2011-02-24       Impact factor: 7.446

3.  Synthesis and in vitro pharmacological evaluation of indolyl carboxylic amide analogues as D3 dopamine receptor selective ligands.

Authors:  Zhude Tu; Shihong Li; Aixiao Li; Michelle Taylor; David Ho; Maninder Malik; Robert R Luedtke; Robert H Mach
Journal:  Medchemcomm       Date:  2013-09       Impact factor: 3.597

4.  Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands.

Authors:  Xin Peng; Qi Wang; Yogesh Mishra; Jinbin Xu; David E Reichert; Maninder Malik; Michelle Taylor; Robert R Luedtke; Robert H Mach
Journal:  Bioorg Med Chem Lett       Date:  2014-12-17       Impact factor: 2.823

5.  Involvement of nucleus accumbens dopamine D1 receptors in ethanol drinking, ethanol-induced conditioned place preference, and ethanol-induced psychomotor sensitization in mice.

Authors:  Amine Bahi; Jean-Luc Dreyer
Journal:  Psychopharmacology (Berl)       Date:  2012-01-06       Impact factor: 4.530

6.  Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes.

Authors:  Mohammed Ahmed Fouad Shalaby; Hekma A Abd El Latif; Mohamed El Yamani; May Ahmed Galal; Sherifa Kamal; Ikhlas Sindi; Raneem Masaood
Journal:  BMC Pharmacol Toxicol       Date:  2021-10-26       Impact factor: 2.483

7.  Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats.

Authors:  Mohammed Fouad Shalaby; Hekma A Abd El Latif; Mohamed El Yamani; May Ahmed Galal; Sherifa Kamal; Ikhlas Sindi
Journal:  Curr Ther Res Clin Exp       Date:  2021-10-12

8.  The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study.

Authors:  Vin-Cent Wu; Che-Hsiung Wu; Ya-Wen Yang; Kuo-How Huang; Chia-Hui Chang; Shao-Yu Yang; Yen-Hung Lin; Kwan-Dun Wu
Journal:  Oncotarget       Date:  2017-09-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.